SCHEMBL5063409

SCHEMBL5063409

COC(=O)c1ccc(-c2ncco2)cc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM4 Q8TD43 1/20 0.50
GLRA3 O75311 1/20 0.50
GLRB P48167 1/20 0.50
CFTR P13569 1/20 0.46
BRD4 O60885 1/20 0.44
ACLY P53396 1/20 0.43
PDK2 Q15119 1/20 0.42
NOTUM Q6P988 1/20 0.42
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
NFKB1 P19838 1/20 0.40
RAB9A P51151 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ATR Q13535 1/20 0.40
ABL1 P00519 1/20 0.39
LTA4H P09960 3/20 0.39
P2RX7 Q99572 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5058922 0.84 TRPM4 (0.55) TRPM4BRD4ACLYPDK2SMN1; SMN2
SCHEMBL5058995 0.83 TRPM4 (0.48) TRPM4GLRA3GLRBBRD4ACLY
SCHEMBL23292530 0.81 GLRA3 (0.50) TRPM4GLRA3GLRBCFTRBRD4
SCHEMBL2884923 0.79 PDK2 (0.57) PDK2NOTUMNPC1MAPTNFKB1
SCHEMBL15896819 0.79 GLRA3 (0.56) TRPM4GLRA3GLRBCFTRBRD4
SCHEMBL3349057 0.77 GLRA3 (0.60) GLRA3GLRBNPC1MAPTNFKB1
SCHEMBL22000615 0.76 ACLY (0.49) TRPM4ACLYLTA4HP2RX7ALDH1A1
SCHEMBL6434655 0.75 GLRA3 (0.62) GLRA3GLRBNPC1RAB9ASMN1; SMN2
SCHEMBL17188047 0.75 PDK2 (0.44) PDK2NOTUMNPC1MAPTNFKB1
SCHEMBL475724 0.74 GLRA3 (0.77) GLRA3GLRBCFTRBRD4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080161294-A1 Urea derivative, medicinal composition containing the same, and medicinal use of these KISSEI PHARMACEUTICAL CO., LTD. (JP) 2008-07-03 US disclosed
EP-1867639-A1 UREA DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL USE OF THESE Kissei Pharmaceutical Co., Ltd. (JP) 2007-12-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161294-A1 Urea derivative, medicinal composition containing the same, and medicinal use of these AVPR2, UTS2R, GPR119 TRPM4 1583/4885GLRA3 425/4885GLRB 431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.